Publikationen
2024
Lingel H, Fischer L, Remstedt S, Kuropka B, Philipsen L, Han I, Sander JE, Freund C, Aditya A, Brunner-Weinzierl MC. 2024. SLAMF7 (CD319) on activated CD8+ T cells transduces environmental cues to initiate cytotoxic effector cell responses. Cell Death & Differentiation. 2024 Oct
https://doi.org/10.1038/s41418-024-01399-y
Álvaro-Benito M, Abualrous ET, Lingel H, Meltendorf S, Holzapfel J, Sticht J, Kuropka B, Clementi C, Kuppler F, Brunner-Weinzierl MC, Freund C. 2024. New Results: Effective assessment of CD4+ T cell Immunodominance patterns: impact of antigen processing and HLA restriction. bioRxiv preprint, 2024 Jan.
https://doi.org/10.1101/2024.01.10.574975
2023
Vogel K, Arra A, Lingel H, Bretschneider D, Prätsch F, Schanze D, Zenker M, Balk S, Bruder D, Geffers R, Hachenberg T, Arens C, Brunner-Weinzierl MC. 2023. Bifidobacteria shape antimicrobial T-helper cell responses during infancy and adulthood. Nat Commun. 2023 Sep 23;14(1):5943. https://doi: 10.1038/s41467-023-41630-x PMID: 37741816
Salerno F, Howden AJM, Matheson LS, Gizlenci Ö, Screen M, Lingel H, Brunner-Weinzierl MC, Turner M. 2023. An integrated proteome and transcriptome of B cell maturation defines poised activation states of transitional and mature B cells. Nat Commun. 2023 Aug 23;14(1):5116. Free PMC article. https://doi: 10.1038/s41467-023-40621-2 PMID: 37612319
Arra A, Lingel H, Pierau M, Brunner-Weinzierl MC. 2023. PD-1 limits differentiation and plasticity of Tc17 cells. Front. Immunol., 14:1104730. Begutachteter Zeitschriftenartikel. https://doi.org/10.3389/fimmu.2023.1104730
Majer C, Lingel H, Arra A, Heuft HG, Bretschneider D, Balk S, Vogel K, Brunner-Weinzierl MC. 2023. PD-1/PD-L1 Control of Antigen-Specifically Activated CD4 T-Cells of Neonates. International Journal of Molecular Sciences, MDPI AG, Bd. 24(6), 5662. Begutachteter Zeitschriftenartikel. https://doi.org/10.3390/ijms24065662
Morhart P, Kehl S, Schuh W, Hermes K, Meltendorf S, Neubert A, Schneider M, Brunner-Weinzierl MC, Schneider H, Lingel H. 2023. Age-related Differences in Immune Reactions to SARS-CoV-2 Spike and Nucleocapsid Antigens. In Vivo 2023 Jan-Feb;37(1):70-78. https://doi.org/10.21873/invivo.13055 PMID: 36593041
Vogel K, Brunner-Weinzierl MC. 2023. Das Bifidobakterium infantis als Wächter des Immunsystems. MEDIZIN AKTUELL Ärzteblatt Sachsen-Anhalt 34 (2023)12:28-29.
https://www.aerzteblatt-sachsen-anhalt.de/images/archiv/PDF/2023/23_heft_12.pdf
2022
Jamaludeen N, Lehmann J, Beyer Ch, Vogel K, Pierau M, Brunner-Weinzierl MC, Spiliopoulou M. 2022. Assessment of Immune Status Using Inexpensive Cytokines: A Literature Review and Learning Approaches. Sensors 2022, 22(24), 9785. Bibliographie: Begutachteter Zeitschriftenartikel. https://doi.org/10.3390/s22249785
Meltendorf S, Vogel K, Thurm Ch, Prätsch F, Reinhold A, Färber J, Heuft HG, Kaasch A, Hachenberg T, Weinzierl S, Schraven B, Reinhold D, Brunner-Weinzierl MC, Lingel H. 2022. IL-13 determines specific IgE responses and SARS-CoV-2 immunity after mild COVID-19 and novel mRNA vaccination. European Journal of Immunology 2022 Oct 22. https://doi.org/10.1002/eji.202249951. PMID: 36271745
Zenke S, Sica MP, Steinberg F, Braun J, Zink A, Gavrilov A, Hilger A, Arra A, Brunner-Weinzierl MC, Elling R, Beyersdorf N, Lämmermann T, Smulski CR, Rohr JC. 2022. Differential trafficking of ligands trogocytosed via CD28 versus CTLA4 promotes collective cellular control of co-stimulation. Nature Communications 2022 Oct 13:6459. https://doi.org/10.1038/s41467-022-34156-1
2021
Lingel H, Meltendorf S, Billing U, Thurm Ch, Vogel K, Majer Ch, Prätsch F, Roggenbuck D, Heuft HG, Hachenberg T, Feist E, Reinhold D, Brunner-Weinzierl MC. 2021. Unique Autoantibody prevalence in long-term recovered SARS-CoV-2-infected Individuals. Journal of autoimmunity - London: Academic Press, Bd. 122 (2021), insges. 8 S.; Impact: 7.094. Bibliographie: Begutachteter Zeitschriftenartikel. https://doi.org/10.1016/j.jaut.2021.102682
Jamaludeen N, Beyer Ch, Billing U, Vogel K, Brunner-Weinzierl MC, Spiliopoulou M. 2021. Potential of point-of-care and at-home assessment of immune status via rapid cytokine detection and questionnaire-based anamnesis. Sensors 2021, 21(15), 4960. Bibliographie: Begutachteter Zeitschriftenartikel. https://doi.org/10.3390/s21154960
Arra A, Pech M, Fu H, Lingel H, Braun F, Beyer C, Spiliopoulou M, Bröker BM, Lampe L, Arens C, Vogel K, Pierau M, Brunner-Weinzierl MC. 2021. Immune-checkpoint blockade of CTLA-4 (CD152) in antigen-specific human T-cell responses differs profoundly between neonates, children, and adults. Oncoimmunology. 2021 Jun 14; 10(1): 1938475. https://doi:10.1080/2162402X.2021.1938475, PMCID: PMC8204976, PMID: 34178430
Korthals M, Tech L, Langnaese K, Gottfried A, Hradsky J, Thomas U, Zenclussen AC, Brunner-Weinzierl MC, Tedford K, Fischer KD. 2020. Plasma membrane Ca2+ ATPase 1 (PMCA1) but not PMCA4 is critical for B-cell development and Ca2+ homeostasis in mice. Eur J Immunol. 2021 Mar;51(3):594-602. https://doi:10.1002/eji.202048654. Epub 2020 Nov 16.Eur J Immunol. 2021. PMID: 33098669.
Pierau M, Arra A, Brunner-Weinzierl MC. 2021. Preventing Atopic Diseases During Childhood – Early Exposure Matters. Front. Immunol. 2021 Feb 25. https://doi.org/10.3389/fimmu.2021.617731, PMCID: PMC7946845, PMID: 33717110
2020
Korthals M, Tech L, Langnaese K, Gottfried A, Hradsky J, Thomas U, Zenclussen AC, Brunner-Weinzierl MC, Tedford K, Fischer KD. 2020. Plasma membrane Ca2+ ATPase 1 (PMCA1) but not PMCA4 is critical for B-cell development and Ca2+ homeostasis in mice. Eur J Immunol. 2020 Oct 24. https://doi.org/10.1002/eji.202048654. Online ahead of print. PMID: 33098669
Knolle J, Pierau M, Hebel K, Lampe K, Jorch G, Kropf S, Arens C, Brunner-Weinzierl MC. 2020. Children from the age of three show a developmental switch in T-cell differentiation. Frontiers in immunology. 11: 1640. https://doi.org/10.3389/fimmu.2020.01640
Meltendorf S, Fu H, Pierau M, Lindquist J, Finzel S, Mertens PR, Ambach A, Thomas U, Lingel H, Voll RE, Brunner-Weinzierl MC. 2020. Cell Survival Failure in Effector T Cells From Patients With Systemic Lupus Erythematosus Following Insufficient Up-Regulation of Cold-Shock Y-Box Binding Protein 1. Arthritis & rheumatology (Hoboken, N.J.). https://doi.org/10.1002/art.41382
Pierau M, Lingel H, Vogel K, Arra A, Brunner-Weinzierl MC. 2020. CTLA-4-competent conventional T-cells back up regulatory T-cells to restrain memory T-helper type 2 cell responses. Allergy. 75(3): 684–687. https://doi.org/10.1111/all.14042
2019
Lingel H, Brunner-Weinzierl MC. 2019. CTLA-4 (CD152): A versatile receptor for immune-based therapy. Seminars in Immunology. 2019 Apr; 42:101298. Review. PMID: 31604536. https://doi.org/10.1016/j.smim.2019.101298
Pierau M, Lingel H, Vogel K, Arra A, Brunner-Weinzierl MC. 2019. CTLA-4-competent conventional T-cells back up regulatory T-cells to restrain memory T-helper type 2 cell responses. Allergy. 2019 Sep 10. doi: 10.1111/all.14042. [Epub ahead of print] No abstract available. PMID: 31505050. https://doi.org/10.1111/all.14042
Yshii L, Pignolet B, Mauré E, Pierau M, Brunner-Weinzierl MC, Hartley O, Bauer J, Liblau R. 2019. IFN-γ is a therapeutic target in paraneoplastic cerebellar degeneration.JCI Insight. 2019 Apr 4;4(7). pii: 127001. doi: 10.1172/jci.insight.127001.eCollection 2019 Apr 4. PMID: 30944244. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483638/pdf/jciinsight-4-127001.pdf
2018
Brunner-Weinzierl MC, Rudd CE. 2018. CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy. Front Immunol 9: link: https://doi.org/10.3389/fimmu.2018.02737
Vogel K, Pierau M, Arra A, Lampe K, Schlüter D, Arens C, Brunner-Weinzierl MC. 2018. Developmental induction of human T-cell responses against Candida albicans and Aspergillus fumigatus. Sci Rep 8: 16904. link: https://www.ncbi.nlm.nih.gov/pubmed/30442915
Brunner-Weinzierl MC, Kopp M. 2018. Paradigmenwechsel in der Allergieprävention. Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde - Berlin: Springer, Bd. 166.2018, 8, S. 708-713. link: https://www.springermedizin.de/paediatrische-allergologie/stillen--saeuglingsnahrung--beikost/paradigmenwechsel-in-der-allergiepraevention/15768050
Lingel H, Schanze D, Zenker M, Brunner-Weinzierl MC. 2018. Translation-inhibitor PDCD4-bound mRNAs in CD8+ T lymphocytes. Repositorium OVGU. DOI 10.24352/UB.OVGU-2018-143
2017
Lingel H, Wissing J, Arra A, Schanze D, Lienenklaus S, Klawonn F, Pierau M, Zenker M, Jänsch L, Brunner-Weinzierl MC. 2017. CTLA-4-mediated post-translational modifications direct cytotoxic T lymphocyte differentiation. Cell Death Differ 24, 1739–1749
Arra A, Lingel H, Kuropka B, Pick J, Schnoeder T, Fischer T, Freund C, Pierau M, Brunner-Weinzierl MC. 2017. The differentition and plasticity of Tc17 cells are regulated by CTLA-4-mediated effects on STATs. Oncoimmunol 6:e1273300
Bernhardt A, Fehr A, Brandt S, Jerchel S, Ballhause TM, Philipsen L, Stolze S, Geffers R, Weng H, Fischer KD, Isermann B, Brunner-Weinzierl MC, Batra A, Siegmund B, Zhu C, Lindquist JA, Mertens PR. 2017. Inflammatory cell infiltration and resolution of kidney inflammation is orchestrated by the cold-shock protein Y-box binding protein-1. Kidney Int 92:1157-1177
Ranjan S, Goihl A, Gadi I, Kohli S, Pierau M, Shahzad K, Bock F, Wang H, Shaikh H, Reinhold D, Zenclusen A, Brunner-Weinzierl MC, Fischer T, Kalinski T, Schraven B, Luft T, Hühn J, Heidel FH, Isermann B. 2017. Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cells. Nat Commun 8:311
Gieseler-Halbach S, Meltendorf S, Pierau M, Weinert S, Heidel FG, Fischer T, Handschuh J, Braun-Dullaeus RC, Schrappe M, Lindquist JA, Mertens PR, Thomas U, Brunner-Weinzierl MC. 2017. RSK-mediated nuclear accumulation of the cold-shock Y-box protein-1 controls proliferation of T cells in T-ALL blasts. Cell Death Differ 24: 371-383
2016
Cammann C, Rath A, Reichl U, Lingel H, Brunner-Weinzierl MC, Simeoni L, Schraven B, Lindquist JA. 2016. Early changes in the metabolic profile of activated CD8+ T cells. BMC Cell Biol 17: 28.
Schmiedeberg K, Krause K, Röhl FW, Hartig R, Jorch G, Brunner-Weinzierl MC. 2016. T cells of infants are mature, but hyporeactive due to limited Ca2+ influx. PLoS ONE 11:e0166633.
Yshii LM, Gebauer CM, Pignolet B, Mauré E, Quériault C, Pierau M, Saito H, Suzuki N, Brunner-Weinzierl MC, Bauer J, Liblau R. 2016. CTLA4 blockade elicits paraneoplastic neurological disease in a mouse model. BRAIN 139: 2923-2934.
2014
Pick J, Arra A, Lingel H, Hegel JK, Huber M, Nishanth G, Jorch G, Fischer KD, Schlüter D, Tedford K, Brunner-Weinzierl MC. 2014. CTLA-4 (CD152) enhances the Tc17 differentiation program. Eur J Immunol 44: 2139-2152.
Hebel K, Weinert S, Kuropka B, Knolle J, Kosak B, Jorch G, Arens C, Krause E, Braun-Dullaeus R, Brunner-Weinzierl MC. 2014. CD4+ T cells from Human Neonates and Infants Are Poised Spontaneously To Run a Nonclassical IL-4 program. J Immunol 192:5160-5170.
Stojanovic A, Fiegler N, Brunner-Weinzierl MC, Cerwenka A. 2014. CTLA-4 is expressed by activated mouse NK cells and inhibits NK Cell IFN-y production in response to mature dendritic cells. J Immunol 192:4184-4191.
Wolleschak D, Mack TS, Perner F, Frey S, Schnöder TM, Wagner MC, Höding C, Pils MC, Parkner A, Kliche S, Schraven B, Hebel K, Brunner-Weinzierl MC, Ranjan S, Isermann B, Lipka DB, Fischer T, Heidel FH. 2014. Clinically relevant doses of FLT3-kinase inhibitors quizartinib and midostaurin do not impair T-cell reactivity and function. Haematologica 99:e90-93.
2013
Hebel K, Pierau M, Lingel H, Steiner M, Krause H, Jorch G, Brunner-Weinzierl MC. 2013. The neonatal immune system: modulation by regulatory T-cells and CTLA-4. J Laboratory Medicine 3:131.
Gimsa U, Mitchison NA, Brunner-Weinzierl MC. 2013. Immune privilege as an intrinsic CNS property: astrocytes protect the CNS against T-cell-mediated neuroinflammation. Mediators Inflamm 320519.
Schwaiger T, van den Brandt C, Fitzner B, Zaatreh S, Kraatz F, Dummer A, Nizze H, Evert M, Bröker B, Brunner-Weinzierl MC, Salem T, Lerch MM, Jaster R and Mayerle J. (2013) Autoimmune pancreatitis in MRL/Mp mice is a T-cell mediated disease responsive to cyclosporine A and rapamycin treatment. Gut 63:494-505.
Atanackovic D, Nowottne U, Freier E, Weber CS, Meyer S, Bartels K, Hildebrandt Y, Cao Y, Kröger N, Brunner-Weinzierl MC, Bokemeyer C, Deter HC. 2013. Acute psychological stress increases peripheral blood CD3±CD56± natural killer T cells in healthy men: possible implications for the development and treatment of allergic and autoimmune disorders. Stress 16:421-428.
Smida M, Cammann C., Gurbiel S, Kerstin N, Lingel H, Lindquist S, Simeoni, L, Brunner-Weinzierl MC, Suchanek M, Schraven, B, Lindquist, JA. 2013. PAG/Cbp suppression reveals a contribution of CTLA-4 to setting the activation threshold in T cells. Cell Commun Signal 11:28.
2012
Körmendy D, Hoff H, Hoff P, Bröker BM, Burmester GR and Brunner-Weinzierl MC. 2012. The impact of the CTLA-4/CD28 axis on the processes of Joint Inflammation in Rheumatoid Arthritis. Arthritis & Rheuma 65:81-87.
Wienecke J, Hebel K, Hegel K, Pierau M, Brune T, Reinhold D, Pethe A and Brunner-Weinzierl MC. 2011. Pro-inflammatory effector Th cells transmigrate through anti-inflammatory environments into the murine fetus. Placenta 33:39-46.
Knieke K, Lingel H, Chamaon K and Brunner-Weinzierl MC. 2012. Migration of Th1 lymphocytes is regulated by CD152 (CTLA-4)-mediated signaling via PI3 kinase-dependent Akt activation. PloS ONE 7:e313914.
Thaventhiran JE, Hoffmann A, Magiera L, de la Roche M, Lingel H, Brunner-Weinzierl MC and Fearon DT. 2012. Activation of the Hippo pathway by CTLA-4 regulates the expression of Blimp-1 in the CD8+ T cell. Proc Natl Acad Sci U S A. 109:E2223-2229.
Gieseler S und Brunner-Weinzierl MC. 2012. Kinder zeigen erhöhtes Infektionsrisiko unter Intensivtherapie. Deutscher Ärzte-Verlag DIVI 3:64-67.
2011
Kolar P, Hoff H, Maschmeyer P, Burmester GR and Brunner-Weinzierl MC. 2011. CTLA-4 (CD152) blockade does not cause a pro-inflammatory cytokine profile in regulatory T cells. Clin Exp Rheumatol 29:254-260.
Rudolph M, Hebel K, Miyamura Y, Maverakis E and Brunner-Weinzierl MC. 2011. Blockade of CTLA-4 decreases the generation of multifunctional memory CD4+ T cells in vivo. J Immunol 186:5580-5589.
Hebel K, Rudolph M and Brunner-Weinzierl MC. 2011. IL-1β and TGF-β act antagonistically in induction and differentially in propagation of human proinflammatory precursor CD4+ T cells. J Immunol 187:5627-5635.
Neumann M, Klar S, Wilisch-Neumann A, Hollenbach E, Kavuri S, Leverkus M, Kandolf R, Klingel K and Brunner-Weinzierl MC. 2011. Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation. Oncogene 30:2485-2492.
Brunner-Weinzierl MC. 2011. Infektionsrisiko unter Intensivtherapie. DIVI. Spectator- Congress 11/12 2011.
2010
Luna RM, Körmendy D and Brunner-Weinzierl MC. 2010. Female-biased incidence of Experimental Autoimmune Encephalomyelistis refects sexual dimorphic expression of CTLA-4 (CD152) on T-lymphocytes. Gender Medicine 7: 296-308.
Schnee B, Marangolo M, Bokemeyer C, Deter HC, Freier E, Weber CS, Nowottne U, Horn C, Meyer S, Hildebrandt Y, Luetkens T, Cao Y, Pabst C, Muzzulini J, Schnee B, Brunner-Weinzierl MC, Marangolo M, Deter HC and Atanackovic D. 2010. Decrease of CD4(+)FOXP3(+) T regulatory cells in the peripheral blood of human subjects undergoing a mental stressor. Psychoneuroendocrinol 35:663-673.
2009
Kolar P, Hoff H, Knieke K, Burmester GR and Brunner-Weinzierl MC. 2009. CTLA-(CD152) controls homeostasis and supressive capacity of regulatory T cells. Arthritis & Rheuma 60:123-132.
Hegel JK, Knieke K, Kolar P, Reiner SL and Brunner-Weinzierl MC. 2009. CD152 (CTLA‐4) regulates effector functions of CD8+ T lymphocytes by repressing Eomesodermin. Eur J Immunol 39:883-893.
Knieke K, Hoff H, Quandt D, Kolar P and Brunner-Weinzierl MC. 2009. CD152 (CTLA-4) determines CD4 T cell migration in vitro and in vivo. PloS ONE 4:e5702.
Freier E, Weber CS, Nowottne U, Horn C, Bartels K, Meyer S, Hildebrandt Y, Luetkens T, Cao Y, Pabst C, Muzzulini J, Schnee B, Brunner-Weinzierl MC, Marangolo M, Bokemeyer C, Deter HC and Atanackovic D. 2009. Decrease of CD4+FOXP3+ peripheral T regulatory cells during a stress-induced activation of the adaptive immune response. Psychoneuroendocrinol 35:663-673.
Hoff H, Cabail Z, Hirseland H, Knieke K, Vratsanos G, Burmester GR, Nadler SG, Bröker B, Hebel K and Brunner-Weinzierl MC. 2009. Surface CD152 (CTLA-4) expression and signaling dictates longevity of CD28null T cells. J Immunol 182: 5342-5351.
Hoff H, Kolar P, Ambach A, Radbruch A and Brunner-Weinzierl MC. 2009. CTLA-(CD152) inhibits T cell function by activating the ubiquitin ligase ITCH. Mol Immunol 47:1875-1881.
Kolar P, Hoff H, Knieke K, Burmester GR and Brunner-Weinzierl MC. 2009. Comment: Regulatory T-cells: CTLA-4 (CD152) in the spotlight. Arthritis & Rheuma 60:2849-285.
Hegel J, Pick J, Hebel K, Krause H, Reiner S and Brunner-Weinzierl MC. 2009. Effector functions of CD8+ T-cells are controlled by costimulation targeting Eomesodermin: Implications for tumor therapy. Annex of the Proceedings of the 16th European Immunology Meeting - EFIS. Monduzzi editore. Bolognia, Italy
Hebel K, Zulema C, Burmester GR, Jorch G, Hirseland H, Vratsanos G, Nadler S and Brunner-Weinzierl MC. 2009. The biological CTLA4Ig reduces CD28 null T cells in a patient suffering from RA: a new way of therapy. Annex of the Proceedings of the 16th European Immunology Meeting - EFIS. Monduzzi editore. Bolognia, Italy.
2007
Hoff H and Brunner-Weinzierl MC. 2007. The tyrosine phosphatase SHP-2 regulates differentiation and apoptosis of individual primary T-lymhocytes. Eur J Immunol. 37:1072-1086.
Pandiyan P, Hegel JK, Krueger M, Quandt D and Brunner-Weinzierl MC. 2007. High IFN-gamma production of individual CD8 T lymphocytes is controlled by CD152 (CTLA-4). J Immunol 178:2132-2140.
Quandt D, Holger H, Fillatraeu S, Radbruch A and Brunner-Weinzierl MC. 2007. A new role for CD152 (CTLA-4) in B cells of TD immune responses in vivo. J Immunol 179:7316-7324.
2006
Gartner D, Hoff H, Gimsa U, Burmester GR and Brunner-Weinzierl MC. 2006. CD25 regulatory T cells determine secondary but not primary remission in EAE: Impact on long-term disease progression. J Neuroimmunol 172: 73-84.
Atanackovic D, Schnee B, Schuch G, Faltz C, Schulze J, Weber CS, Schafhausen P, Bartels K, Bokemeyer C, Brunner-Weinzierl MC and Deter HC. 2006. Acute psychological stress alerts the adaptive immune response: Stress-induced mobilization of effector T cells. J Neuroimmunol 176: 141-152.
2004
Gimsa U, Pandiyan P, Nitsch R and Brunner-Weinzierl MC. 2004. Astrocytes protect the CNS: antigen-specific T helper cell responses are inhibited by astrocyte-induced upregulation of CTLA-4 (CD152). J Mol Med 82:364-372.
Pandiyan P, Gärtner D, Soezeri O, Radbruch A, Schulze-Osthoff K and Brunner-Weinzierl MC. 2004. CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3´kinase function. J Exp Med 199: 831-842.
Brunner-Weinzierl MC, Hoff H and Burmester GR. 2004. Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses: implications for arthritis and autoimmune diseases. Arthritis Res Ther 6:45-54.
2003
Atanackovic D, Schulze J, Kröger, H, Brunner-Weinzierl MC and Deter HC. 2003. Acute psychological stress induces a prolonged suppression of the production of reactive oxygen species by phagocytes. J Neuroimmunol 142:159-165.
Maszyna F, Kunkel D, Radbruch A and Brunner-Weinzierl MC. 2003. Diversity of clonal T cell proliferation is mediated by differential expression of CD152 (CD152) on the cell surface of activated individual T lymphocytes J Immunol 171:3459-3466.
2002
Lehmann J, Huehn J, de la Rosa M, Maszyna F, Veitt K, Brunner-Weinzierl MC, Scheffold A and Hamann A. 2002. Expression of the integrin E7 defines a unique subset of CD25+ as well as CD25- regulatory T cells. PNAS 99: 31031-31036.
Atanackovic D, Brunner-Weinzierl MC, Kröger H, Serke S and Deter HC. 2002. Acute psychological stress simultaneously alters hormone levels, recruitment of lymphocyte subsets, and production of reactive oxygen species. Immunol Invest 32: 73-91.
1999
Brunner MC, Chambers C, Chan F, Winoto A and Allison JP. 1999. CTLA-4 mediated inhibition of early events of T cell proliferation. J. Immunol. 162: 5813-5820.
Brunner MC. Costimulatory molecules and modulation. The Immunologist 7: 9-12
1996
Brunner-MC, Larsen S, Sette A and Mitchison NA. 1996. Altered Th1/Th2 balance associated with the immunosuppressive/protective effect of the H-2Ab allele on the response to allo-4-hydroxyphenylpyruvate dioxygenase. Euro J Immunol 25:3285-3289.
Brunner MC and Mitchison NA. 1996. Control by non-MHC genes of the allo-4-hydroxyphenylpyruvate dioxygenase (F-protein) response. Immunology 88:452-455.
Allison JP, Chambers CA, Hurwitz A, Sullivan TJ, Boitel B, Fournier S, Brunner MC and Krummel MF. 1998. A role for CD152-mediated inhibitory signals in peripheral T cell tolerance? Immunological Tolerance. Novartis Foundation. John Wiley and Sons, Inc., New York, Weinheim, Brisbane, Singapore, Toronto.
Chambers CA, Krummel MF, Boittel B, Hurwitz A, Sullivan TJ, Fournier S, Cassell D, Brunner, MC and Allison JP. 1996. The role of CD152 in the regulation and initiation of T cell responses. Immunol Rev 153:27.
1995
Mitchison NA and Brunner MC. 1995. Protection against collagen-induced arthritis by H-2Ab: A possible role for the MHC class II promoter. Immunogenetics 41:239-245.
Brunner MC. 1995. T-cell cytokine responses associated with a protective major histocompatibility complex class II allele. Dissertation, Freie Universität Berlin.
Bayrak S, Bregulla M, Brunner MC, Mitchison NA and Schneider SC. 1995. New principles in self-tolerance and autoimmunity: First-Past-the-Post, inhibitory cytokines mediating protection by major histocompatibility complex gene, triggered by infection. Immunol Res S1:568, S. Karger AG, Basel
1994
Brunner MC, Schneider SC and Mitchison NA. 1994. The integrative activity of the immune system. Scand J Immunol 40:479-80.
Brunner MC, Mitchison NA and Schneider SC. 1994. Immunoregulation mediated by T cell clusters. Folia biologica 40:359-69.
Brunner MC, Mitchison NA, Sieper J and Simon K. 1994. Cytokine profile as a predisposing or protective factor in immunological diseases: present information, prospects for intervention, the need for cytokine-based epidemiology. Immunotherapy of Infections. Chapter 3, Marcel Dekker, Inc., New York.
1992
Brunner MC. 1992. Charakterisierung des C-terminalen, Rezeptor-bindenden Areals des Anaphylatoxins C3a mit Hilfe von synthetischen Peptiden und monoklonalen Antikörpern. Diplomarbeit. Freie Universität Berlin.
Brunner MC, Caput D, Helbert M, Mitchison NA, Simon K and Wu P, 1992. Regulation of regulatory T-cells. Progress in Immunol 7:627.